Tom Cohen

GSK Buys CureVac’s mRNA Vaccine Business Providing Welcome Cash Injection

—

by

Tom Cohen
in

CureVac will continue to build its R&D pipeline while allowing GSK to develop and commercialise a handful of its prophylactic mRNA vaccines.

Read More

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *